Cryotherapy: Science and Benefits of Cerene

On-Demand Webinar
HCP Resources Page
image
Description
In this comprehensive webinar, experts learn more about the innovative Cerene Cryotherapy Device, a significant advancement in the treatment of heavy menstrual bleeding. The session explores the science behind cryotherapy and its application in endometrial ablation, highlighting the Cerene Device's role in providing a minimally invasive alternative to more extensive surgical procedures. The webinar is an essential resource for healthcare professionals seeking to understand the evolution of endometrial ablation techniques, patient outcomes, and the practical application of the Cerene device in clinical settings.  

Key Takeaways
 
  1. Innovative Approach to Endometrial Ablation: The webinar emphasizes the Cerene Cryotherapy Device as a groundbreaking tool in endometrial ablation. This innovative approach utilizes cryotherapy technology to to provide a desired reduction in heavy menstrual bleeding effectively and safely, while minimizing the risks associated with major surgery.
  2. Enhanced Patient Outcomes and Satisfaction: The discussion highlights the positive outcomes of using the Cerene Device, including high rates of patient satisfaction and reduced bleeding. It is noted that 92% of patients reported pain levels at or below the acceptable median during treatment. The device's preservation of intrauterine access and allowance for future evaluations in most uterine cavities is also underscored.
  3. Clinical Trial Results and Safety Profile: The webinar presents data from the Clarity trial, demonstrating the Cerene Device's effectiveness and safety. 77% of women achieved a significant reduction in bleeding (according to the FDA benchmark) and 96% maintained the ability to evaluate for pathological changes post-ablation. Additionally, the lack of serious adverse events related to the device or procedure reinforces its safety profile.
Complete the Form Below to View
Now Playing
Video Library
Barbara Levy, MD moderates a discussion with Geoffrey Bowers, MD and Leslie Hansen Lindner, MD on their insights on the evolution of endometrial ablation and how innovations in cryotherapy may reshape thinking around heavy menstrual bleeding treatment.
A compilation of physician perspectives on the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
Barbara Levy, MD discusses the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
James Greenberg, MD and Barbara Levy, MD discuss the implications from recent and historical publications on the rates of hysterectomy after an endometrial ablation.
James Coad, MD and Andrew Brill, MD discuss the science and benefits of cryotherapy for endometrial ablation.
Barbara Levy, MD and Todd Rumsey, MD discuss patient selection criteria for the Cerene Cryotherapy Device (27 minutes).
Barbara Levy, MD along with panelists Robert Rubino, MD, Richard Salter, MD, and Shannon Smith, MD provide insights into the management of menorrhagia. (59 minutes)
Barbara Levy, MD and Gerard Reilly, MD discuss how new innovations in cryotherapy are transforming the treatment of heavy menstrual bleeding. (45 minutes)

Important Safety Information

Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More